{"abstract": "Carl C. Icahn, the billionaire activist investor, and the hedge fund Eastbourne Capital Management asserted Wednesday afternoon that they had prevailed in their quest to place their handpicked nominees on the board of Amylin Pharmaceuticals.", "web_url": "https://dealbook.nytimes.com/2009/05/27/amylin-dissidents-say-they-won-board-seats/", "snippet": "Carl C. Icahn, the billionaire activist investor, and the hedge fund Eastbourne Capital Management asserted Wednesday afternoon that they had prevailed in their quest to place their handpicked nominees on the board of Amylin Pharmaceuticals.", "lead_paragraph": "Update | 3:49 p.m. Carl C. Icahn, the billionaire activist investor, and the hedge fund Eastbourne Capital Management prevailed Wednesday in their quest to place their handpicked nominees on the board of Amylin Pharmaceuticals.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Dissidents Win Two Seats on Amylin\u2019s Board", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-05-27T18:49:23+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Zachery Kouwe", "person": [{"firstname": "Zachery", "middlename": null, "lastname": "Kouwe", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/97d32c5e-a53d-555d-9b0c-7a29edbafc6a", "word_count": 626, "uri": "nyt://article/97d32c5e-a53d-555d-9b0c-7a29edbafc6a"}